Table 1.
General characteristic of the included studies.
| Study (year) | Mean symptom duration (ESWT/control) | No. ESWT/control | Male patients (ESWT/control) | Mean age (ESWT/control) | Mean BMI (ESWT/control) | Mean follow-up time | Outcomes |
|---|---|---|---|---|---|---|---|
| Yang 2015 | 5.06/5.26 mo | 29/29 | 3/2 | 32.27/33.27 | NS | 5 wk | VAS score |
| Wu 2016 | 6.32/7.42 wk | 28/26 | 17/14 | 46.14/48.77 | 20.91/20.61 | 4 wk | VAS score, ODI score |
| Moon 2017 | 20.42/17.7 mo | 14/11 | 3/1 | 54.42/59.18 | NS | 4 wk | NRS score, ODI score |
| Walewicz 2019 | 9.8/9 yr | 20/20 | 6/5 | 51.1/55.8 | NS | 3 mo | VAS score, ODI score |
| Çelik 2019 | 36/33 mo | 25/20 | 15/8 | 40.76/40.25 | NS | 6 wk | NRS score, ODI score |
| Schneider 2018 | 25.2/18.9 mo | 15/15 | NS | NS | NS | 3 wk | VAS score |
| Walewicz 2019 | 8.5/7.6 yr | 20/20 | 6/0 | 51.1/55.8 | NS | 17 wk | VAS score, ODI score |
| Eftekharsadat 2020 | NS | 27/27 | 7/10 | 44.74/45.04 | 27.47/26.20 | 4 wk | VAS score, ODI score |
| Elgendy 2020 | NS | 15/15 | 10/10 | 32.73/33.26 | 24.93/25.56 | 6 wk | VAS score |
| Guo 2021 | NS | 47/48 | 25/23 | 34.9/36.0 | 22.3/22.7 | 4 wk | NRS score |
| Kang 2015 | 5.2/3.9 yr | 22/21 | NS | 43.1/42.5 | NS | 8 wk | VAS score, ODI score |
| NAHAS 2018 | 15.6/13.4 mo | 15/15 | 0/0 | 29.40/29.20 | 26.68/25.81 | 4 wk | VAS score |
| Taheri 2021 | 6.7/5.8 yr | 19/19 | 6/9 | 42.5.37.1 | 27.1/26.8 | 12 wk | VAS score, ODI score |
| Zheng 2013 | 7.52/6.89 yr | 33/33 | 18/25 | 45.84/47.39 | NS | 2 wk | VAS score |
BMI = body mass index, ESWT = extracorporeal shock wave therapy, NRS = numeric rating scale, ODI = Oswestry Disability Index, VAS = Visual Analog Scale.